Australian dementia research needs increased representation of people from culturally and linguistically diverse backgrounds
Evidence‐based practice and policy must be based on the best available evidence, which should be representative of the population.1 However, the current body of dementia research does not reflect the ethnic and cultural diversity of the Australian population. Hence, people from culturally and linguistically diverse (CALD) backgrounds may receive inequitable dementia care as there is less evidence to help optimise clinical and service decisions.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Djulbegovic B, Guyatt GH. Progress in evidence‐based medicine: a quarter century on. Lancet 2017; 390: 415–423.
- 2. Babulal GM, Quiroz YT, Albensi BC, et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimers Dement 2018; 15: 292–312.
- 3. Low LF, Anstey KJ, Lackersteen SM, Camit M. Help‐seeking and service use for dementia in Italian, Greek and Chinese Australians. Aging Ment Health 2011; 15: 397–404.
- 4. Ramamoorthy A, Pacanowski MA, Bull J, Zhang L. Racial/ethnic differences in drug disposition and response: review of recently approved drugs. Clin Pharmacol Ther 2014; 97: 263–273.
- 5. Pfeffer N. Theories of race, ethnicity and culture. BMJ 1998; 317: 1381–1384.
- 6. Scarmeas N, Stern Y. Cognitive reserve and lifestyle. J Clin Exp Neuropsychol 2003; 25: 625–633.
- 7. Geboers B, Uiters E, Reijneveld SA, et al. Health literacy among older adults is associated with their 10‐years' cognitive functioning and decline — the Doetinchem Cohort Study. BMC Geriatr 2018; 18: 77.
- 8. Alzheimer's Australia Vic. Perceptions of dementia in ethnic communities. Melbourne: Alzheimer's Australia Vic, 2008. https://www.dementia.org.au/files/20101201-Nat-CALD-Perceptions-of-dementia-in-ethnic-communities-Oct08.pdf (viewed Sept 2019).
- 9. Aoun SM, Toye C, Slatyer S, et al. A person‐centred approach to family carer needs assessment and support in dementia community care in Western Australia. Health Soc Care Community 2018; 26: e578–e586.
- 10. Brett L, Traynor V, Stapley P, Meedya S. Exercise and dementia in nursing homes: views of staff and family carers. J Aging Phys Act 2018; 26: 89–96.
- 11. Baker FA, Stretton‐Smith P, Clark IN, et al. A group therapeutic songwriting intervention for family caregivers of people living with dementia: a feasibility study with thematic analysis. Front Med (Lausanne) 2018; 5: 151.
- 12. Regan B, Wells Y, Farrow M, et al. MAXCOG‐Maximizing Cognition: a randomized controlled trial of the efficacy of goal‐oriented cognitive rehabilitation for people with mild cognitive impairment and early Alzheimer disease. Am J Geriatr Psychiatry 2017; 25: 258–269.
- 13. Henwood T, Neville C, Baguley C, Beattie E. Aquatic exercise for residential aged care adults with dementia: benefits and barriers to participation. Int Psychogeriatr 2017; 29: 1439–1449.
- 14. Vyas MV, Raval PK, Watt JA, Tang‐Wai DF. Representation of ethnic groups in dementia trials: systematic review and meta‐analysis. J Neurol Sci 2018; 394: 107–111.
- 15. Dementia Centre for Research Collaboration. Australian cohorts and longitudinal studies measuring dementia outcomes [website]. DCRC, 2017. http://www.dementiaresearch.org.au/popuation-health/2-uncategorised/218-cohort-studies.html (viewed Jan 2019).
- 16. Australian Institute of Health and Welfare. Dementia in Australia (Cat. No. AGE 70). Canberra: AIHW, 2012. https://www.aihw.gov.au/getmedia/199796bc-34bf-4c49-a046-7e83c24968f1/13995.pdf.aspx?inline=true (viewed Sept 2019).
- 17. Australian Institute of Health and Welfare. Older Australians at a glance (Cat. No. AGE 87). Canberra: AIHW, 2018. https://www.aihw.gov.au/reports/older-people/older-australia-at-a-glance/contents/summary (viewed Nov 2018).
- 18. Brown L, Hansnata E, La HA. Economic cost of dementia in Australia 2016–2056. Canberra: University of Canberra, 2017. https://www.dementia.org.au/files/NATIONAL/documents/The-economic-cost-of-dementia-in-Australia-2016-to-2056.pdf (viewed Sept 2019).
- 19. NHMRC National Institute for Dementia Research (NNIDR). Australia's Boosting Dementia Research Initiative: report on early outcomes. Canberra: Commonwealth of Australia, 2018. https://www.nnidr.gov.au/sites/default/files/files/Boosting%20Dementia%20Research%20Initiative%20Early%20Outcomes%20Report.PDF (viewed Sept 2019).
- 20. Ellis KA, Ai Bush, Darby D, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 2009; 21: 672–687.
- 21. Heffernan M, Andrews F, Fiatarone Singh MA, et al. Maintain your brain: protocol of a 3‐year randomized controlled trial of a personalized multi‐modal digital health intervention to prevent cognitive decline among community dwelling 55 to 77 year olds. J Alzheimers Dis 2019; 70: S221–S237.
- 22. Dementia Australia. Australian Dementia Network (ADNeT) Registry and Clinical Trials Program [website]. Dementia Australia, 2018. https://www.dementia.org.au/news/2018/australian-dementia-network-adnet-registry-and-clinical-trials-program (viewed Feb 2019).
- 23. Haralambous B, Tinney J, LoGiudice D, et al. Interpreter‐mediated cognitive assessments: who wins and who loses? Clin Gerontol 2018; 41: 227–236.
- 24. Panayiotou A, Gardner A, Williams S, et al. Can language translation applications be safely used in a health care setting? Expert opinion. JMIR Mhealth Uhealth 2019; 7: e11316.
- 25. Brijnath B, Ellis S, Croy S. CALD dementia research action plan. AJDC 2019; 8: 14.
- 26. Liu KA, Mager NAD. Women's involvement in clinical trials: historical perspective and future implications. Pharm Pract (Granada) 2016; 14: 708.
- 27. Knepper TC, McLeod HL. When will clinical trials finally reflect diversity? Nature 2018; 557: 157–159.
- 28. Food and Drug Administration. Collection of race and ethnicity data in clinical trials. FDA, 2016. https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf (viewed Sept 2019).
- 29. Rowland JT, Basic D, Storey JE, Conforti DA. The Rowland Universal Dementia Assessment Scale (RUDAS) and the Folstein MMSE in a multicultural cohort of elderly persons. Int Psychogeriatr 2006; 18: 111–120.
- 30. Brewster P, Barnes L, Haan M, et al. Progress and future challenges in aging and diversity research in the United States. Alzheimers Dement 2019; 15: 995–1003.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
The data presented in this article were funded by the NNIDR as part of the development of the CALD Dementia Research Roadmap. Lee‐Fay Low is funded through an NHMRC Boosting Dementia Research Leadership Development Fellowship. The NNIDR were involved in conceptualising the article, but not in analysis or interpretation.
Bianca Brijnath has financial relationships with government and private foundations for research and policy development specific to CALD communities and dementia.